Comments
Dr. Reddy’s Laboratories has launched Montelukast Sodium tablets in 10 mg and Montelukast Sodium Chewable tablets (4 mg & 5 mg).
The drug is a bioequivalent generic version of SINGULAIR® tablets and Chewable tablets.
The Hyderabad-based pharma major launched it in the US market on August 6, following approval by the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA).
The Singular tablets and Chewable tablets brand had US sales of approximately $3.6 billion and $1.14 billion, respectively for the most recent 12 months ended March 31, 2012, according to IMS Health.
Dr. Reddy’s Montelukast Sodium tablets in 10 mg and Montelukast Sodium Chewable tablets in 4 mg and 5 mg are available in bottle counts of 30 and 90, a company release said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.